FTC sues major pharmacy benefit managers over insulin price ranges The company introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing price of lifestyle-preserving insulin medicine. The offer should be completed by Sept. 30 or buyers can terminate the https://kethek.com/